Rating History for 8/17/2026
| Company (Firm - Analyst) | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details | ||
|---|---|---|---|---|---|---|---|---|---|
| Abbvie
(Wells Fargo - Mohit Bansal) |
ABBV | Maintain | Overweight (N/A) |
300.00 (295.00) |
|
Details | |||
| Acadia Pharmaceuticals
(UBS - Ashwani Verma) |
ACAD | Maintain | Buy (N/A) |
49.00 (45.00) |
|
Details | |||
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 283 more... | |||||||||
